12:00 AM
 | 
Aug 28, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Inverse agonists of the serotonin 5HT2A receptor regulatory update

ARNA and partner TRPS received U.S. Patent No. 6,107,324 covering small molecule compounds that non-competitively inhibit the serotonin...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >